As artificial intelligence continues to redefine industries, its most transformative impact in biotech is happening b ...

Offer of US$3.01 in cash plus one contingent value right for potential additional aggregate payments of up to US$1.19 per ...

Antibody therapies constitute a vast global market: currently valued at over $250 billion, the market for antibodies is ...

In the past week, bluebird bio named new leaders after its acquisition, Dyne secured a debt deal and ProFound Therapeutics ...

The Future of Health, Medicine, and Biotechnology: Part 8 RIT / Osher Lifelong Learning Institute / Calendar / The Future of Health, Medicine, and Biotechnology: Part 8 Wednesday, July 09, 2025 1:30 ...

The situation was reversed only 25 years ago. So, the Biotech Centre of Excellence will project the group towards the future of medicine and science.

Trinity Biotech projects it reached Adjusted EBITDA1 -positive operations during Q2 2025 and expects to be Adjusted EBITDA1 positive going forward, reflecting continued strong execution on its ...

As scientific breakthroughs continue to transform medicine in 2025, companies across the biotech and pharmaceutical sectors ...

HQH offers high yields with a biotech and small/mid-cap tilt, but relies on capital payouts, making it less tax efficient and ...

The much-anticipated second annual edition of the Biotechnology Show continues to attract industry giants, creating a powerful platform for innovation, collaboration, and deal-making. With an ...